More Zelira Therapeutics Ltd. news Zelira Therapeutics Ltd.ASX: ZLD ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled Sep 15, 2022 at 2:47 AM UTC · Issued by Zelira Therapeutics Ltd. As issuedPlain English Zelira Therapeutics Ltd has released a press release. View Attachment